Last update:

Oncology & Cancer news

Oncology & Cancer

Risk for second melanoma up for those with first melanoma diagnosis

Patients with a first melanoma diagnosis have an increased risk for a second melanoma diagnosis, regardless of race and ethnicity, according to a research letter published online Oct. 9 in JAMA Dermatology.

Oncology & Cancer

Study uncovers mutations and DNA structures driving bladder cancer

How bladder cancer originates and progresses has been illuminated as never before in a study led by researchers at Weill Cornell Medicine and the New York Genome Center. The researchers found that antiviral enzymes that mutate ...

Oncology & Cancer

Do people with MS have an increased risk of cancer?

A study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. The study is published in the October 9, 2024, online issue of Neurology. Types of cancers found ...

Oncology & Cancer

Rapid blood cancer diagnostic could speed decisions and save lives

Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately detects the presence ...

Oncology & Cancer

New insights into glioblastoma treatment for elderly patients

A study led by Dr. Monika E. Hegi, MD, Ph.D. and European Organization for Research and Treatment of Cancer (EORTC) headquarters team (Felix Oppong Msc, Dr. Thierry Gorlia, Ph.D.) reveals that elderly glioblastoma patients ...

Oncology & Cancer

Cell line models identify cause of melanoma with drug resistance

Melanoma is a type of cancer that originates from melanocytes, the cells responsible for producing skin pigment, and is known as the most lethal form of skin cancer due to its high rates of metastasis and recurrence. With ...

Oncology & Cancer

Drugmaker GSK says EU to review womb cancer treatment

British pharmaceutical giant GSK said on Tuesday that the EU's drug watchdog will study a new treatment for a common type of womb cancer for potential approval in the European market.

Oncology & Cancer

Study explains how 'zombie' cancer cells revive themselves

Mutating cells can prevent the spread of cancer by flipping themselves into a state of reduced activity called senescence. Cancer genes, however, can retaliate by reviving those cells so they can replicate again.

Oncology & Cancer

Scientists use genetics to dig into a tumor's past

For patients with some types of cancer, diagnosis can happen at an advanced stage. While a tumor grows unnoticed, it accumulates hundreds to thousands of mutations, making it difficult for scientists studying late-stage cancers ...

Oncology & Cancer

AI algorithm may help better guide oropharynx cancer treatment

For patients with human papilloma virus (HPV)-associated oropharynx cancer, assessing the presence of cancer cells beyond the lymph nodes, or extranodal extension (ENE), is critical in determining proper treatment. However, ...

Oncology & Cancer

Patients with IBD found to be at higher risk of lymphoma

The risk of developing lymphoma is slightly elevated in inflammatory bowel disease (IBD) and has increased in recent years in patients with Crohn's disease, report researchers from Karolinska Institutet in a study published ...

Oncology & Cancer

Men need to take melanoma seriously

It's only April, but many people across the country and the globe are already enjoying summerlike temperatures. But getting out in the sun also increases your risk of getting skin cancer.

Oncology & Cancer

Examining three types of head and neck cancers

April is Head and Neck Cancer Awareness Month, which makes this a good time to learn about three types of cancer that affect these areas of the body.

Oncology & Cancer

New lung immuno-oncology therapeutic strategy identified

Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated in a preclinical study a potential new therapeutic approach to treating the most common form of lung cancer.

Oncology & Cancer

Cancer researchers identify new target for breast cancer therapy

While trying to understand what initiates breast cells to become cancerous, researchers at the Vera Bradley Foundation Center for Breast Cancer Research at Indiana University Melvin and Bren Simon Comprehensive Cancer Center ...

Medical research

Researchers describe a new method to test cancer drug toxicity

For people with cancer, chemotherapy saves lives, but for some patients, the treatment comes with a side effect—heart damage. Screening cancer drugs for cardiotoxicity has been an ongoing challenge, as heart cells don't ...

Oncology & Cancer

Researchers discover pathway critical for lymphoma development

MYC proteins are important regulators of cancer cell growth, proliferation and metabolism through their ability to increase the expression of proteins involved in these processes. Deregulation of MYC proteins occurs in more ...